Skip to content
Review

Survival benefit of adding carboplatin to standard anthracycline–taxane chemotherapy in triple-negative breast cancer: an updated systematic review and meta-analysis

Nov 2026 · Breast Cancer Research and Treatment · Vol 220 · 0 citations · 26 references
View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.